COMBINED ENERGOTROPIC CORRECTION OF PATHOBIOCHEMICAL DISORDERS DURING VASCULAR LIVER EXCLUSION IN THE EXPERIMENT
POSSIBILITIES OF USING SELECTIVE CHELATION THERAPY TO CORRECT PATHOBIOCHEMICAL CHANGES IN EXPERIMENTAL ISCHEMIA-REPERFUSION INJURY OF THE LIVER
INFLUENCE OF DICHLOROACETATE ON PYRUVATE DEHYDROGENASE ACTIVITY AND LIVER DAMAGE DURING ISCHEMIA-REPERFUSION IN EXPERIMENTAL CONDITIONS
INFLUENCE OF PRECONDITIONING WITH PRO-/ANTIOXIDANTS ON THE DEVELOPMENT OF ISCHEMIA-REPERFUSION LIVER DAMAGE IN EXPERIMENTAL CONDITIONS
